RxDoctor Payments DataLook up a doctor →

Barry McLean, MD

Internal Medicine · Homewood, ALNPI 1588634679

Payments from drug & device makers

$4,035,873in general payments, 2019–2025

Across 1,764 payments — averaging $2287.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech, Inc.$1.4M
  • Bavarian Nordic A/s$1.3M
  • Novartis$446K
  • Pfizer$350K
  • Acella Pharmaceuticals, LLC$161K
  • Novo Nordisk AS$152K
  • plus $193K from 54 others
$5,501in research payments, 2019–2025

Across 3 payments — averaging $1833.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • F. Hoffmann-la Roche AG$6K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Genentech, Inc.34$1,393,557
Bavarian Nordic A/s76$1,340,659
Novartis37$446,346
Pfizer97$349,773
Acella Pharmaceuticals, LLC9$160,799
Novo Nordisk AS30$152,125
Alnylam Pharmaceuticals Inc.188$69,650
Teva Pharmaceuticals USA, Inc.12$28,189
AstraZeneca74$21,971
Regeneron6$15,472
Avion Pharmaceuticals3$14,946
Ironwood Pharmaceuticals, Inc2$7,504
First Wave Biopharma, Inc.1$5,250
Kowa Research Institute, Inc.2$4,123
Amryt Pharma Holdings Ltd8$2,978
Novo Nordisk176$2,950
Roche Products Limited1$2,430
Lilly USA, LLC124$1,818
AbbVie(2 entities)141$1,505
Johnson & Johnson101$1,281
Bayer61$1,167
Esperion Therapeutics, Inc.20$1,077
Amarin Pharma, Inc.68$1,030
Orasure Technologies Inc.1$1,000
Amgen59$975
Sanofi-aventis U.S. LLC47$827
Abbott39$748
Kowa Pharmaceuticals America, Inc.45$543
Dexcom, Inc.22$497
Merck33$490
Takeda Pharmaceuticals U.S.A., Inc.30$472
Boehringer Ingelheim29$449
Astellas Pharma US Inc24$358
Xeris Pharmaceuticals, Inc.17$328
Corcept Therapeutics16$291
Antares Pharma, Inc.11$230
Shield Therapeutics Inc12$199
Exact Sciences12$199
GSK9$190
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC10$189
Azurity Pharmaceuticals, Inc.9$158
E.r. Squibb & Sons, L.L.C.9$136
Medtronic(2 entities)7$110
Halozyme Inc4$105
Boston Scientific6$104
Arbor Pharmaceuticals, Inc.6$101
Phathom Pharmaceuticals, Inc.6$93
Mannkind Corporation7$86
Tolmar, Inc.4$64
Almatica Pharma LLC3$57
Lifescan, Inc.3$51
Idorsia Pharmaceuticals US Inc3$42
Paratek Pharmaceuticals, Inc.2$30
Pacira Therapeutics, Inc.1$28
Ultragenyx Pharmaceutical Inc.1$27
Assertio Therapeutics, Inc.2$26
IBSA Pharma Inc.1$18
Hikma Pharmaceuticals USA1$17
Eisai Inc.1$15
Sumitomo Pharma America, Inc.1$13

How this compares

$4,035,873 in reported general payments places this provider in the 95th percentile of 1,533 internal medicine providers in Alabama.

See all internal medicine providers in Alabama →

Medicare billing

Part B allowed, 2024
$140,404
Medicare patients
304
Services billed
76,533

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Homewood

See the full list for Alabama →

Where these figures come from

Is this you, or does something look wrong? →